{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:01:36Z","timestamp":1780340496819,"version":"3.54.1"},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Turkish Institutes of Health","award":["32543"],"award-info":[{"award-number":["32543"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antimetabolites, primarily studied in cancer, are novel drugs targeting metabolic networks by mimicking and inhibiting disease-causing metabolites, enabling poly-pharmacologic effects essential for complex diseases. Moreover, predicting patients likely to positively respond to antimetabolite drugs is necessary to simplify clinical applications. However, existing computational approaches for antimetabolite target discovery lack incorporation of disease-induced metabolic state perturbations, and their applicability beyond cancer remains unexplored. We introduce MATADOR (Metabolite-centric Analysis of TArgets for Drug ORientation), a computational workflow that integrates patient-derived omic data with metabolic networks to identify, evaluate, and prioritize antimetabolite targets based on metabolic state transformation. Applying MATADOR to RNA-seq data from breast, colon, lung, and liver cancers, we achieved a 66\u2009\u00b1\u20096% sensitivity in recapturing known antimetabolite targets, strongly supported thioredoxin as a pan-cancer antimetabolite drug target, and linked top-ranked targets to poor 5-year survival in breast and liver cancers. Extending beyond cancer, MATADOR nominated metabolites with proinflammatory effects as potential antimetabolite targets in Alzheimer\u2019s and Parkinson\u2019s diseases, aligning well with their known pathological mechanisms. Finally, applying MATADOR on personalized metabolic networks, machine learning models trained on metabolic gene expression demonstrated the ability to leverage gene expression to personalize antimetabolite targets. The proposed approach may expedite prioritization and personalization of antimetabolite targets during pre-clinical studies across diseases with systemic metabolic alterations.<\/jats:p>","DOI":"10.1093\/molecular-omics\/aaiag018","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:41:05Z","timestamp":1778182865000},"source":"Crossref","is-referenced-by-count":0,"title":["Metabolite-centric identification of antimetabolite drug targets across cancer and neurodegenerative diseases"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-7477","authenticated-orcid":false,"given":"Regan","family":"Odongo","sequence":"first","affiliation":[{"name":"Department of Bioengineering, Gebze Technical University , Kocaeli 41400 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunahan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, Gebze Technical University , Kocaeli 41400 ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026060114035948900_ref1","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/msb.145122","article-title":"Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling","volume":"10","author":"Agren","year":"2014","journal-title":"Mol Syst Biol"},{"key":"2026060114035948900_ref2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"2026060114035948900_ref3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/ijc.29495","article-title":"Thymidylate synthase expression in circulating tumor cells: a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients","volume":"137","author":"Abdallah","year":"2015","journal-title":"Int J Cancer"},{"key":"2026060114035948900_ref4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/B978-0-323-95502-7.00227-X","volume-title":"Encyclopedia of Bioinformatics and Computational Biology","author":"\u00c7ak\u0131r","year":"2025","edition":"2"},{"key":"2026060114035948900_ref5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.cmet.2017.02.002","article-title":"Systems biology of metabolism: a driver for developing personalized and precision medicine","volume":"25","author":"Nielsen","year":"2017","journal-title":"Cell Metab"},{"key":"2026060114035948900_ref6","doi-asserted-by":"publisher","first-page":"e03641","DOI":"10.7554\/eLife.03641","article-title":"Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer","volume":"3","author":"Yizhak","year":"2014","journal-title":"eLife"},{"key":"2026060114035948900_ref7","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1093\/bioinformatics\/btq602","article-title":"iMAT: an integrative metabolic analysis tool","volume":"26","author":"Zur","year":"2010","journal-title":"Bioinformatics"},{"key":"2026060114035948900_ref8","doi-asserted-by":"publisher","first-page":"e1002518","DOI":"10.1371\/journal.pcbi.1002518","article-title":"Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT","volume":"8","author":"Agren","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"2026060114035948900_ref9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-0716-2655-9_9","volume-title":"Alzheimer\u2019s Disease: Methods and Protocols, Methods in Molecular Biology","author":"L\u00fcleci","year":"2023"},{"key":"2026060114035948900_ref10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41540-024-00448-z","article-title":"A benchmark of RNA-seq data normalization methods for transcriptome mapping on human genome-scale metabolic networks","volume":"10","author":"L\u00fcleci","year":"2024","journal-title":"NPJ Syst Biol Appl"},{"key":"2026060114035948900_ref11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41514-021-00064-9","article-title":"Abnormal brain cholesterol homeostasis in Alzheimer\u2019s disease\u2014a targeted metabolomic and transcriptomic study","volume":"7","author":"Varma","year":"2021","journal-title":"NPJ Aging Mech Dis"},{"key":"2026060114035948900_ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3632","article-title":"Model-based identification of drug targets that revert disrupted metabolism and its application to ageing","volume":"4","author":"Yizhak","year":"2013","journal-title":"Nat Commun"},{"key":"2026060114035948900_ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00916","article-title":"Metabolic network-based identification and prioritization of anticancer targets based on expression data in hepatocellular carcinoma","volume":"9","author":"Bidkhori","year":"2018","journal-title":"Front Physiol"},{"key":"2026060114035948900_ref14","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.1038\/srep08183","article-title":"Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling","volume":"5","author":"Ghaffari","year":"2015","journal-title":"Sci Rep"},{"key":"2026060114035948900_ref15","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.xcrm.2020.100138","article-title":"Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer\u2019s disease","volume":"1","author":"Baloni","year":"2020","journal-title":"Cell Rep Med"},{"key":"2026060114035948900_ref16","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1093\/BIOINFORMATICS\/BTZ231","article-title":"rMTA: robust metabolic transformation analysis","volume":"35","author":"Valc\u00e1rcel","year":"2019","journal-title":"Bioinformatics"},{"key":"2026060114035948900_ref17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41698-020-0122-1","article-title":"Machine learning approaches to drug response prediction: challenges and recent progress","volume":"4","author":"Adam","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"2026060114035948900_ref18","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1038\/s41467-022-33291-z","article-title":"Gene expression based inference of cancer drug sensitivity","volume":"13","author":"Chawla","year":"2022","journal-title":"Nat Commun"},{"key":"2026060114035948900_ref19","doi-asserted-by":"publisher","first-page":"eadz9283","DOI":"10.1126\/sciadv.adz9283","article-title":"AI-driven discovery of dual antiaging and anti-AD therapeutics via PROTAC target deconvolution of a super-enhancer\u2013regulated axis","volume":"11","author":"Sun","year":"2025","journal-title":"Sci Adv"},{"key":"2026060114035948900_ref20","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol"},{"key":"2026060114035948900_ref21","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/NAR\/GKV1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026060114035948900_ref22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s42255-023-00817-8","article-title":"A multimodal atlas of tumour metabolism reveals the architecture of gene\u2013metabolite covariation","volume":"5","author":"Benedetti","year":"2023","journal-title":"Nat Metab"},{"key":"2026060114035948900_ref23","doi-asserted-by":"publisher","first-page":"180142","DOI":"10.1038\/sdata.2018.142","article-title":"A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research","volume":"5","author":"De Jager","year":"2018","journal-title":"Sci Data"},{"key":"2026060114035948900_ref24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb5398","article-title":"Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets","volume":"7","author":"Neff","year":"2021","journal-title":"Sci Adv"},{"key":"2026060114035948900_ref25","doi-asserted-by":"publisher","article-title":"A study of gene expression in the living human brain","author":"Liharska","DOI":"10.1038\/s41380-025-03163-1"},{"key":"2026060114035948900_ref26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12859-018-2246-7","article-title":"Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons","volume":"19","author":"Smid","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2026060114035948900_ref27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026060114035948900_ref28","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaz1482","article-title":"An atlas of human metabolism","volume":"13","author":"Robinson","year":"2020","journal-title":"Sci Signal"},{"key":"2026060114035948900_ref29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41596-018-0098-2","article-title":"Creation and analysis of biochemical constraint-based models using the COBRA toolbox v.3.0","volume":"14","author":"Heirendt","year":"2019","journal-title":"Nat Protoc"},{"key":"2026060114035948900_ref30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nbt.1614","article-title":"What is flux balance analysis?","volume":"28","author":"Orth","year":"2010","journal-title":"Nat Biotechnol"},{"key":"2026060114035948900_ref31","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026060114035948900_ref32","doi-asserted-by":"publisher","first-page":"15112","DOI":"10.1073\/pnas.232349399","article-title":"Analysis of optimality in natural and perturbed metabolic networks","volume":"99","author":"Segr\u00e8","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026060114035948900_ref33","volume-title":"Metabolic Modeling of Anti-Cancer CD8 t Cells and Sars-COV-2 Infection","author":"Cheng","year":"2021"},{"key":"2026060114035948900_ref34","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2202.01908","article-title":"Sampling with Riemannian Hamiltonian Monte Carlo in a constrained space","author":"Kook","year":", 2022"},{"key":"2026060114035948900_ref35","doi-asserted-by":"publisher","first-page":"100625","DOI":"10.1016\/j.xinn.2024.100625","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","author":"Gy\u0151rffy","year":"2024","journal-title":"Int J Hydrog Energ"},{"key":"2026060114035948900_ref36","doi-asserted-by":"publisher","first-page":"15534","DOI":"10.1038\/s41598-020-72664-6","article-title":"How to do quantile normalization correctly for gene expression data analyses","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci Rep"},{"key":"2026060114035948900_ref37","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1145\/2939672.2939785","volume-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","author":"Chen","year":"2016"},{"key":"2026060114035948900_ref38","volume-title":"Advances in Neural Information Processing Systems","author":"Ke","year":"2017"},{"key":"2026060114035948900_ref39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net. J. R","volume":"67","author":"Zou","year":"2005","journal-title":"Stat Soc Ser B Stat Methodol"},{"key":"2026060114035948900_ref40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"2026060114035948900_ref41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10115-013-0679-x","article-title":"Explaining prediction models and individual predictions with feature contributions","volume":"41","author":"\u0160trumbelj","year":"2014","journal-title":"Knowl Inf Syst"},{"key":"2026060114035948900_ref42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41598-023-51034-y","article-title":"Transcriptome-based biomarker prediction for Parkinson\u2019s disease using genome-scale metabolic modeling","volume":"14","author":"Abdik","year":"2024","journal-title":"Sci Rep"},{"key":"2026060114035948900_ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep14563","article-title":"Reporter pathway analysis from transcriptome data: metabolite-centric versus reaction-centric approach","volume":"5","author":"\u00c7akir","year":"2015","journal-title":"Sci Rep"},{"key":"2026060114035948900_ref44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41531-023-00563-4","article-title":"Neuroprotective role for RORA in Parkinson\u2019s disease revealed by analysis of post-mortem brain and a dopaminergic cell line","volume":"9","author":"Al-Zaid","year":"2023","journal-title":"Npj Park Dis"},{"key":"2026060114035948900_ref45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","article-title":"Roles of bile acids signaling in neuromodulation under physiological and pathological conditions","volume":"13","author":"Xing","year":"2023","journal-title":"Cell Biosci"},{"key":"2026060114035948900_ref46","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00702-014-1293-0","article-title":"Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study","volume":"122","author":"Durrenberger","year":"2015","journal-title":"J Neural Transm"},{"key":"2026060114035948900_ref47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026060114035948900_ref48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12974-019-1659-1","article-title":"The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration","volume":"16","author":"Tu","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2026060114035948900_ref49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-017-1297-5","article-title":"Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer\u2019s disease","volume":"14","author":"Marksteiner","year":"2017","journal-title":"Metabolomics"},{"key":"2026060114035948900_ref50","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1096\/fj.201600275R","article-title":"Effects of bile acids on neurological function and disease","volume":"30","author":"McMillin","year":"2016","journal-title":"FASEB J"},{"key":"2026060114035948900_ref51","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.14336\/AD.2020.0217","article-title":"Alteration of metabolic profile and potential biomarkers in the plasma of Alzheimer\u2019s disease","volume":"11","author":"Shao","year":"2020","journal-title":"Aging Dis"},{"key":"2026060114035948900_ref52","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol Aging"},{"key":"2026060114035948900_ref53","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0002-9440(10)62347-4","article-title":"Fatty acid oxidation in the pathogenesis of Alzheimer\u2019s disease","volume":"166","author":"Montine","year":"2005","journal-title":"Am J Pathol"},{"key":"2026060114035948900_ref54","doi-asserted-by":"publisher","first-page":"e051134","DOI":"10.1002\/alz.051134","article-title":"Cholesterol metabolism in Alzheimer\u2019s disease","volume":"17","author":"Phenix","year":"2021","journal-title":"Alzheimers Dement"},{"key":"2026060114035948900_ref55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer\u2019s disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat Neurosci"},{"key":"2026060114035948900_ref56","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1073\/pnas.0701549104","article-title":"Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide","volume":"104","author":"Lu","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"2026060114035948900_ref57","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.coph.2007.04.003","article-title":"Thioredoxin signaling as a target for cancer therapy","volume":"7","author":"Powis","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"2026060114035948900_ref58","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2023-187197","article-title":"Association between high antimetabolite dose intensity during maintenance, toxicities and relapse risk in children with acute lymphoblastic Leukemia (ALL): COG-AALL03N1 report","volume":"142","author":"Wadhwa","year":"2023","journal-title":"Blood"},{"key":"2026060114035948900_ref59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/bjc.2013.333","article-title":"A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7\/DOX breast cancer cells","volume":"109","author":"Kim","year":"2013","journal-title":"Br J Cancer"},{"key":"2026060114035948900_ref60","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/bcr2895","article-title":"Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11gene expression in forming surface P-selectin ligands in aggressive breast cancer cells","volume":"13","author":"Cooney","year":"2011","journal-title":"Breast Cancer Res"},{"key":"2026060114035948900_ref61","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.3390\/cancers12082252","article-title":"Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer","volume":"12","author":"Varghese","year":"2020","journal-title":"Cancers"},{"key":"2026060114035948900_ref62","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primer"},{"key":"2026060114035948900_ref63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for Parkinson\u2019s disease by metabolomic technologies","volume":"87","author":"Hatano","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026060114035948900_ref64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41531-021-00239-x","article-title":"A six-metabolite panel as potential blood-based biomarkers for Parkinson\u2019s disease","volume":"7","author":"Klatt","year":"2021","journal-title":"Npj Park Dis"},{"key":"2026060114035948900_ref65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog Neurobiol"},{"key":"2026060114035948900_ref66","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1038\/emm.2013.85","article-title":"Cancer cell metabolism: implications for therapeutic targets","volume":"45","author":"Jang","year":"2013","journal-title":"Exp Mol Med"},{"key":"2026060114035948900_ref67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41420-025-02554-1","article-title":"The role and mechanism of fatty acid oxidation in cancer drug resistance","volume":"11","author":"Lei","year":"2025","journal-title":"Cell Death Discov"},{"key":"2026060114035948900_ref68","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","article-title":"Energy metabolism in tumor cells","volume":"274","author":"Moreno-S\u00e1nchez","year":"2007","journal-title":"FEBS J"},{"key":"2026060114035948900_ref69","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tibs.2014.03.001","article-title":"Heparan sulfate signaling in cancer","volume":"39","author":"Knelson","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"2026060114035948900_ref70","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/febs.14748","article-title":"The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer","volume":"286","author":"Pude\u0142ko","year":"2019","journal-title":"FEBS J"},{"key":"2026060114035948900_ref71","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1073\/pnas.0437937100","article-title":"Evidence for defective retinoid transport and function in late onset Alzheimer\u2019s disease","volume":"100","author":"Goodman","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"2026060114035948900_ref72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primer"},{"key":"2026060114035948900_ref73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41538-025-00402-1","article-title":"Impact of vitamin a on aged people\u2019s cognition and Alzheimer\u2019s disease progression in an animal model","volume":"9","author":"Li","year":"2025","journal-title":"NPJ Sci Food"},{"key":"2026060114035948900_ref74","doi-asserted-by":"publisher","first-page":"123010","DOI":"10.1016\/j.lfs.2024.123010","article-title":"Retinoic acid in Parkinson\u2019s disease: molecular insights, therapeutic advances, and future prospects","volume":"355","author":"Pareek","year":"2024","journal-title":"Life Sci"},{"key":"2026060114035948900_ref75","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29577","article-title":"27-Hydroxycholesterol drives the spread of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"38","author":"Dai","journal-title":"Mov Disord"},{"key":"2026060114035948900_ref76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-025-00803-6","article-title":"Lipidome disruption in Alzheimer\u2019s disease brain: detection, pathological mechanisms, and therapeutic implications","volume":"20","author":"He","year":"2025","journal-title":"Mol Neurodegener"},{"key":"2026060114035948900_ref77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"2026060114035948900_ref78","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.3390\/molecules27196229","article-title":"Folic acid antimetabolites (antifolates): a brief review on synthetic strategies and application opportunities","volume":"27","author":"Kovalev","year":"2022","journal-title":"Molecules"},{"key":"2026060114035948900_ref79","doi-asserted-by":"publisher","first-page":"10175","DOI":"10.1002\/chem.201905792","article-title":"The thioredoxin system: a promising target for cancer drug development","volume":"26","author":"Ghareeb","year":"2020","journal-title":"Chem Eur J"},{"key":"2026060114035948900_ref80","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/antiox13091078","article-title":"Exploring the thioredoxin system as a therapeutic target in cancer: mechanisms and implications","volume":"13","author":"Seitz","year":"2024","journal-title":"Antioxidants"},{"key":"2026060114035948900_ref81","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"2026060114035948900_ref82","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","article-title":"Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease","volume":"29","author":"Johnson","year":"2023","journal-title":"Nat Med"},{"key":"2026060114035948900_ref83","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuropharm.2012.08.026","article-title":"Leukotriene D4 induces cognitive impairment through enhancement of CysLT1R-mediated amyloid-\u03b2 generation in mice","volume":"65","author":"Tang","year":"2013","journal-title":"Neuropharmacology"},{"key":"2026060114035948900_ref84","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13195-021-00892-7","article-title":"Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer\u2019s dementia","volume":"13","author":"Xiong","year":"2021","journal-title":"Alzheimer's Res Ther"},{"key":"2026060114035948900_ref85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.201800355RRRR","article-title":"Integrated communications between cyclooxygenase-2 and Alzheimer\u2019s disease","volume":"33","author":"Guan","year":"2019","journal-title":"FASEB J"},{"key":"2026060114035948900_ref86","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41423-019-0294-1","article-title":"Cyclooxygenase-2 is critical for the propagation of \u03b2-amyloid protein and reducing the glycosylation of tau in Alzheimer\u2019s disease","volume":"16","author":"Guan","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"2026060114035948900_ref87","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1093\/brain\/aww117","article-title":"Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice","volume":"139","author":"Woodling","year":"2016","journal-title":"Brain"},{"key":"2026060114035948900_ref88","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s42255-025-01314-w","article-title":"Neuronal glycogen breakdown mitigates tauopathy via pentose-phosphate-pathway-mediated oxidative stress reduction","volume":"7","author":"Bar","year":"2025","journal-title":"Nat Metab"},{"key":"2026060114035948900_ref89","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.2174\/1381612824666180717161338","article-title":"Parkinson\u2019s disease: alpha synuclein, heme oxygenase and biotherapeutic countermeasures","volume":"24","author":"Haines","year":"2018","journal-title":"Curr Pharm Des"},{"key":"2026060114035948900_ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.711396","article-title":"Severe and regionally widespread increases in tissue urea in the human brain represent a novel finding of pathogenic potential in Parkinson\u2019s disease dementia","volume":"14","author":"Scholefield","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"2026060114035948900_ref91","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41531-025-01099-5","article-title":"Urea cycle dysregulation drives metabolic stress and neurodegeneration in Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2025","journal-title":"Npj Park Dis"},{"key":"2026060114035948900_ref92","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0083-6729(02)64005-1","article-title":"Transport of leukotriene C4 and structurally related conjugates","volume":"64","author":"Jedlitschky","year":"2002","journal-title":"Vitam Horm"},{"key":"2026060114035948900_ref93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1208\/s12248-017-0163-8","article-title":"Roles of organic anion transporting polypeptide 2A1 (OATP2A1\/SLCO2A1) in regulating the pathophysiological actions of prostaglandins","volume":"20","author":"Nakanishi","year":"2017","journal-title":"AAPS J"},{"key":"2026060114035948900_ref94","doi-asserted-by":"publisher","first-page":"151406","DOI":"10.1016\/j.ejcb.2024.151406","article-title":"The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier","volume":"103","author":"Kurtyka","year":"2024","journal-title":"Eur J Cell Biol"},{"key":"2026060114035948900_ref95","doi-asserted-by":"publisher","first-page":"eabb1206","DOI":"10.1126\/scitranslmed.abb1206","article-title":"An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Ghosh","year":"2020","journal-title":"Sci Transl Med"}],"container-title":["Molecular Omics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/advance-article-pdf\/doi\/10.1093\/molecular-omics\/aaiag018\/68246393\/aaiag018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/3\/aaiag018\/68246393\/aaiag018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/3\/aaiag018\/68246393\/aaiag018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:04:11Z","timestamp":1780337051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/doi\/10.1093\/molecular-omics\/aaiag018\/8672477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":95,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/molecular-omics\/aaiag018","relation":{},"ISSN":["2515-4184"],"issn-type":[{"value":"2515-4184","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]},"article-number":"aaiag018"}}